nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—Doxorubicin—urinary bladder cancer	0.305	0.5	CbGbCtD
L-Arginine—NOS3—Doxorubicin—urinary bladder cancer	0.305	0.5	CbGbCtD
L-Arginine—NOS3—penis—urinary bladder cancer	0.0143	0.0813	CbGeAlD
L-Arginine—NOS3—umbilical vein—urinary bladder cancer	0.0118	0.067	CbGeAlD
L-Arginine—SLC7A3—prostate gland—urinary bladder cancer	0.0105	0.0598	CbGeAlD
L-Arginine—AZIN2—prostate gland—urinary bladder cancer	0.00937	0.0533	CbGeAlD
L-Arginine—ASL—prostate gland—urinary bladder cancer	0.00871	0.0496	CbGeAlD
L-Arginine—ASL—renal system—urinary bladder cancer	0.00594	0.0338	CbGeAlD
L-Arginine—SLC7A1—prostate gland—urinary bladder cancer	0.00571	0.0325	CbGeAlD
L-Arginine—SLC7A4—female reproductive system—urinary bladder cancer	0.00533	0.0304	CbGeAlD
L-Arginine—Extravasation—Carboplatin—urinary bladder cancer	0.00516	0.0447	CcSEcCtD
L-Arginine—ARG2—prostate gland—urinary bladder cancer	0.00488	0.0278	CbGeAlD
L-Arginine—ASL—female reproductive system—urinary bladder cancer	0.00475	0.0271	CbGeAlD
L-Arginine—AZIN2—vagina—urinary bladder cancer	0.00463	0.0263	CbGeAlD
L-Arginine—Necrosis—Mitomycin—urinary bladder cancer	0.00427	0.037	CcSEcCtD
L-Arginine—SLC7A1—renal system—urinary bladder cancer	0.00389	0.0221	CbGeAlD
L-Arginine—Extravasation—Mitomycin—urinary bladder cancer	0.00384	0.0332	CcSEcCtD
L-Arginine—Skin necrosis—Cisplatin—urinary bladder cancer	0.00378	0.0327	CcSEcCtD
L-Arginine—ARG2—epithelium—urinary bladder cancer	0.00359	0.0204	CbGeAlD
L-Arginine—Skin necrosis—Etoposide—urinary bladder cancer	0.00347	0.03	CcSEcCtD
L-Arginine—ASS1—prostate gland—urinary bladder cancer	0.00342	0.0195	CbGeAlD
L-Arginine—NOS3—prostate gland—urinary bladder cancer	0.00341	0.0194	CbGeAlD
L-Arginine—Injection site reaction—Mitomycin—urinary bladder cancer	0.00333	0.0288	CcSEcCtD
L-Arginine—ARG2—renal system—urinary bladder cancer	0.00333	0.0189	CbGeAlD
L-Arginine—ARG2—urethra—urinary bladder cancer	0.00327	0.0186	CbGeAlD
L-Arginine—SLC7A1—female reproductive system—urinary bladder cancer	0.00312	0.0177	CbGeAlD
L-Arginine—AZIN2—lymph node—urinary bladder cancer	0.00299	0.017	CbGeAlD
L-Arginine—ASS1—seminal vesicle—urinary bladder cancer	0.00289	0.0165	CbGeAlD
L-Arginine—ASL—lymph node—urinary bladder cancer	0.00278	0.0158	CbGeAlD
L-Arginine—ARG2—female reproductive system—urinary bladder cancer	0.00267	0.0152	CbGeAlD
L-Arginine—Haematuria—Valrubicin—urinary bladder cancer	0.0026	0.0225	CcSEcCtD
L-Arginine—ASS1—epithelium—urinary bladder cancer	0.00251	0.0143	CbGeAlD
L-Arginine—NOS3—epithelium—urinary bladder cancer	0.00251	0.0143	CbGeAlD
L-Arginine—SLC16A10—prostate gland—urinary bladder cancer	0.00244	0.0139	CbGeAlD
L-Arginine—ASS1—smooth muscle tissue—urinary bladder cancer	0.00242	0.0138	CbGeAlD
L-Arginine—NOS3—smooth muscle tissue—urinary bladder cancer	0.00242	0.0137	CbGeAlD
L-Arginine—ARG2—vagina—urinary bladder cancer	0.00241	0.0137	CbGeAlD
L-Arginine—ASS1—renal system—urinary bladder cancer	0.00233	0.0133	CbGeAlD
L-Arginine—NOS3—renal system—urinary bladder cancer	0.00233	0.0132	CbGeAlD
L-Arginine—ASS1—urethra—urinary bladder cancer	0.00229	0.013	CbGeAlD
L-Arginine—SLC22A4—prostate gland—urinary bladder cancer	0.00218	0.0124	CbGeAlD
L-Arginine—Skin necrosis—Methotrexate—urinary bladder cancer	0.00208	0.018	CcSEcCtD
L-Arginine—Skin necrosis—Epirubicin—urinary bladder cancer	0.00194	0.0168	CcSEcCtD
L-Arginine—Extravasation—Thiotepa—urinary bladder cancer	0.00193	0.0167	CcSEcCtD
L-Arginine—ASS1—female reproductive system—urinary bladder cancer	0.00187	0.0106	CbGeAlD
L-Arginine—NOS3—female reproductive system—urinary bladder cancer	0.00186	0.0106	CbGeAlD
L-Arginine—SLC22A4—seminal vesicle—urinary bladder cancer	0.00184	0.0105	CbGeAlD
L-Arginine—SLC7A1—lymph node—urinary bladder cancer	0.00182	0.0104	CbGeAlD
L-Arginine—Skin necrosis—Doxorubicin—urinary bladder cancer	0.0018	0.0156	CcSEcCtD
L-Arginine—SLC16A10—epithelium—urinary bladder cancer	0.0018	0.0102	CbGeAlD
L-Arginine—Necrosis—Fluorouracil—urinary bladder cancer	0.00178	0.0154	CcSEcCtD
L-Arginine—ASS1—vagina—urinary bladder cancer	0.00169	0.00961	CbGeAlD
L-Arginine—NOS3—vagina—urinary bladder cancer	0.00168	0.00958	CbGeAlD
L-Arginine—Necrosis—Cisplatin—urinary bladder cancer	0.00168	0.0146	CcSEcCtD
L-Arginine—Numbness—Fluorouracil—urinary bladder cancer	0.00168	0.0146	CcSEcCtD
L-Arginine—Extravasation—Gemcitabine—urinary bladder cancer	0.00163	0.0141	CcSEcCtD
L-Arginine—Sensory loss—Fluorouracil—urinary bladder cancer	0.00161	0.0139	CcSEcCtD
L-Arginine—Skin exfoliation—Thiotepa—urinary bladder cancer	0.00161	0.0139	CcSEcCtD
L-Arginine—Extravasation—Fluorouracil—urinary bladder cancer	0.0016	0.0138	CcSEcCtD
L-Arginine—ARG2—lymph node—urinary bladder cancer	0.00156	0.00887	CbGeAlD
L-Arginine—Necrosis—Etoposide—urinary bladder cancer	0.00154	0.0134	CcSEcCtD
L-Arginine—Extravasation—Cisplatin—urinary bladder cancer	0.00151	0.0131	CcSEcCtD
L-Arginine—SLC22A4—renal system—urinary bladder cancer	0.00148	0.00844	CbGeAlD
L-Arginine—Numbness—Etoposide—urinary bladder cancer	0.00146	0.0126	CcSEcCtD
L-Arginine—SLC22A5—prostate gland—urinary bladder cancer	0.00144	0.0082	CbGeAlD
L-Arginine—Injection site reaction—Gemcitabine—urinary bladder cancer	0.00141	0.0122	CcSEcCtD
L-Arginine—Sensory loss—Etoposide—urinary bladder cancer	0.0014	0.0121	CcSEcCtD
L-Arginine—Extravasation—Etoposide—urinary bladder cancer	0.00139	0.012	CcSEcCtD
L-Arginine—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.00135	0.0117	CcSEcCtD
L-Arginine—SLC16A10—female reproductive system—urinary bladder cancer	0.00133	0.00759	CbGeAlD
L-Arginine—Skin exfoliation—Cisplatin—urinary bladder cancer	0.00126	0.0109	CcSEcCtD
L-Arginine—SLC22A5—seminal vesicle—urinary bladder cancer	0.00122	0.00693	CbGeAlD
L-Arginine—SLC16A10—vagina—urinary bladder cancer	0.00121	0.00687	CbGeAlD
L-Arginine—SLC22A4—female reproductive system—urinary bladder cancer	0.00119	0.00676	CbGeAlD
L-Arginine—Skin exfoliation—Etoposide—urinary bladder cancer	0.00116	0.01	CcSEcCtD
L-Arginine—Swelling—Fluorouracil—urinary bladder cancer	0.00115	0.00993	CcSEcCtD
L-Arginine—Anorexia—Mitomycin—urinary bladder cancer	0.00114	0.00987	CcSEcCtD
L-Arginine—Vomiting—Valrubicin—urinary bladder cancer	0.0011	0.00955	CcSEcCtD
L-Arginine—Rash—Valrubicin—urinary bladder cancer	0.00109	0.00947	CcSEcCtD
L-Arginine—Dermatitis—Valrubicin—urinary bladder cancer	0.00109	0.00946	CcSEcCtD
L-Arginine—ASS1—lymph node—urinary bladder cancer	0.00109	0.00622	CbGeAlD
L-Arginine—NOS3—lymph node—urinary bladder cancer	0.00109	0.0062	CbGeAlD
L-Arginine—Headache—Valrubicin—urinary bladder cancer	0.00109	0.00941	CcSEcCtD
L-Arginine—SLC22A4—vagina—urinary bladder cancer	0.00108	0.00612	CbGeAlD
L-Arginine—Decreased appetite—Mitomycin—urinary bladder cancer	0.00104	0.009	CcSEcCtD
L-Arginine—Lethargy—Fluorouracil—urinary bladder cancer	0.00103	0.00894	CcSEcCtD
L-Arginine—Nausea—Valrubicin—urinary bladder cancer	0.00103	0.00892	CcSEcCtD
L-Arginine—Swelling—Etoposide—urinary bladder cancer	0.000996	0.00862	CcSEcCtD
L-Arginine—SLC22A5—renal system—urinary bladder cancer	0.000982	0.00559	CbGeAlD
L-Arginine—SLC22A5—urethra—urinary bladder cancer	0.000965	0.00549	CbGeAlD
L-Arginine—Necrosis—Methotrexate—urinary bladder cancer	0.000924	0.008	CcSEcCtD
L-Arginine—Haematuria—Thiotepa—urinary bladder cancer	0.000899	0.00778	CcSEcCtD
L-Arginine—Necrosis—Epirubicin—urinary bladder cancer	0.000865	0.00748	CcSEcCtD
L-Arginine—Extravasation—Methotrexate—urinary bladder cancer	0.000831	0.00719	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—urinary bladder cancer	0.0008	0.00692	CcSEcCtD
L-Arginine—SLC22A5—female reproductive system—urinary bladder cancer	0.000787	0.00448	CbGeAlD
L-Arginine—SLC16A10—lymph node—urinary bladder cancer	0.000781	0.00444	CbGeAlD
L-Arginine—Extravasation—Epirubicin—urinary bladder cancer	0.000778	0.00673	CcSEcCtD
L-Arginine—Sweating—Gemcitabine—urinary bladder cancer	0.000761	0.00658	CcSEcCtD
L-Arginine—Vomiting—Mitomycin—urinary bladder cancer	0.00076	0.00658	CcSEcCtD
L-Arginine—Haematuria—Gemcitabine—urinary bladder cancer	0.000756	0.00655	CcSEcCtD
L-Arginine—Rash—Mitomycin—urinary bladder cancer	0.000754	0.00653	CcSEcCtD
L-Arginine—Dermatitis—Mitomycin—urinary bladder cancer	0.000753	0.00652	CcSEcCtD
L-Arginine—Headache—Mitomycin—urinary bladder cancer	0.000749	0.00648	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—urinary bladder cancer	0.00072	0.00623	CcSEcCtD
L-Arginine—SLC22A5—vagina—urinary bladder cancer	0.000711	0.00405	CbGeAlD
L-Arginine—Nausea—Mitomycin—urinary bladder cancer	0.00071	0.00615	CcSEcCtD
L-Arginine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.000697	0.00603	CcSEcCtD
L-Arginine—SLC22A4—lymph node—urinary bladder cancer	0.000695	0.00396	CbGeAlD
L-Arginine—Skin exfoliation—Methotrexate—urinary bladder cancer	0.000692	0.00599	CcSEcCtD
L-Arginine—Injection site reaction—Epirubicin—urinary bladder cancer	0.000675	0.00584	CcSEcCtD
L-Arginine—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000648	0.00561	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.000624	0.0054	CcSEcCtD
L-Arginine—Flushing—Cisplatin—urinary bladder cancer	0.000616	0.00533	CcSEcCtD
L-Arginine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.000605	0.00524	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.0006	0.00519	CcSEcCtD
L-Arginine—Tachycardia—Thiotepa—urinary bladder cancer	0.000587	0.00508	CcSEcCtD
L-Arginine—Anorexia—Thiotepa—urinary bladder cancer	0.000573	0.00496	CcSEcCtD
L-Arginine—Flushing—Etoposide—urinary bladder cancer	0.000564	0.00488	CcSEcCtD
L-Arginine—Lethargy—Methotrexate—urinary bladder cancer	0.000537	0.00465	CcSEcCtD
L-Arginine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000523	0.00452	CcSEcCtD
L-Arginine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000506	0.00438	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—urinary bladder cancer	0.000503	0.00435	CcSEcCtD
L-Arginine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000497	0.0043	CcSEcCtD
L-Arginine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000489	0.00423	CcSEcCtD
L-Arginine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000486	0.0042	CcSEcCtD
L-Arginine—Anorexia—Gemcitabine—urinary bladder cancer	0.000482	0.00417	CcSEcCtD
L-Arginine—Anorexia—Fluorouracil—urinary bladder cancer	0.000474	0.0041	CcSEcCtD
L-Arginine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000472	0.00408	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—urinary bladder cancer	0.000465	0.00403	CcSEcCtD
L-Arginine—Tachycardia—Cisplatin—urinary bladder cancer	0.00046	0.00398	CcSEcCtD
L-Arginine—SLC22A5—lymph node—urinary bladder cancer	0.00046	0.00262	CbGeAlD
L-Arginine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000456	0.00395	CcSEcCtD
L-Arginine—Anorexia—Cisplatin—urinary bladder cancer	0.00045	0.00389	CcSEcCtD
L-Arginine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000443	0.00383	CcSEcCtD
L-Arginine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00044	0.00381	CcSEcCtD
L-Arginine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000432	0.00374	CcSEcCtD
L-Arginine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000432	0.00374	CcSEcCtD
L-Arginine—Tachycardia—Etoposide—urinary bladder cancer	0.000422	0.00365	CcSEcCtD
L-Arginine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000418	0.00361	CcSEcCtD
L-Arginine—Anorexia—Etoposide—urinary bladder cancer	0.000412	0.00356	CcSEcCtD
L-Arginine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00041	0.00355	CcSEcCtD
L-Arginine—Sweating—Methotrexate—urinary bladder cancer	0.000389	0.00337	CcSEcCtD
L-Arginine—Haematuria—Methotrexate—urinary bladder cancer	0.000387	0.00335	CcSEcCtD
L-Arginine—Vomiting—Thiotepa—urinary bladder cancer	0.000382	0.00331	CcSEcCtD
L-Arginine—Rash—Thiotepa—urinary bladder cancer	0.000379	0.00328	CcSEcCtD
L-Arginine—Dermatitis—Thiotepa—urinary bladder cancer	0.000379	0.00328	CcSEcCtD
L-Arginine—Headache—Thiotepa—urinary bladder cancer	0.000377	0.00326	CcSEcCtD
L-Arginine—Decreased appetite—Etoposide—urinary bladder cancer	0.000376	0.00325	CcSEcCtD
L-Arginine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000367	0.00317	CcSEcCtD
L-Arginine—Sweating—Epirubicin—urinary bladder cancer	0.000364	0.00315	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—urinary bladder cancer	0.000362	0.00313	CcSEcCtD
L-Arginine—Nausea—Thiotepa—urinary bladder cancer	0.000357	0.00309	CcSEcCtD
L-Arginine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000347	0.00301	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000339	0.00293	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—urinary bladder cancer	0.000337	0.00291	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—urinary bladder cancer	0.000335	0.0029	CcSEcCtD
L-Arginine—Vomiting—Gemcitabine—urinary bladder cancer	0.000322	0.00278	CcSEcCtD
L-Arginine—Rash—Gemcitabine—urinary bladder cancer	0.000319	0.00276	CcSEcCtD
L-Arginine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000319	0.00276	CcSEcCtD
L-Arginine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000318	0.00275	CcSEcCtD
L-Arginine—Headache—Gemcitabine—urinary bladder cancer	0.000317	0.00274	CcSEcCtD
L-Arginine—Flushing—Epirubicin—urinary bladder cancer	0.000316	0.00274	CcSEcCtD
L-Arginine—Vomiting—Fluorouracil—urinary bladder cancer	0.000316	0.00274	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000314	0.00272	CcSEcCtD
L-Arginine—Rash—Fluorouracil—urinary bladder cancer	0.000314	0.00271	CcSEcCtD
L-Arginine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000313	0.00271	CcSEcCtD
L-Arginine—Headache—Fluorouracil—urinary bladder cancer	0.000312	0.0027	CcSEcCtD
L-Arginine—L-Methionine—MTHFR—urinary bladder cancer	0.000305	1	CrCbGaD
L-Arginine—Nausea—Gemcitabine—urinary bladder cancer	0.000301	0.0026	CcSEcCtD
L-Arginine—Vomiting—Cisplatin—urinary bladder cancer	0.0003	0.00259	CcSEcCtD
L-Arginine—Rash—Cisplatin—urinary bladder cancer	0.000297	0.00257	CcSEcCtD
L-Arginine—Dermatitis—Cisplatin—urinary bladder cancer	0.000297	0.00257	CcSEcCtD
L-Arginine—Nausea—Fluorouracil—urinary bladder cancer	0.000295	0.00256	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—urinary bladder cancer	0.000293	0.00253	CcSEcCtD
L-Arginine—Nausea—Cisplatin—urinary bladder cancer	0.00028	0.00242	CcSEcCtD
L-Arginine—Vomiting—Etoposide—urinary bladder cancer	0.000275	0.00238	CcSEcCtD
L-Arginine—Rash—Etoposide—urinary bladder cancer	0.000272	0.00236	CcSEcCtD
L-Arginine—Dermatitis—Etoposide—urinary bladder cancer	0.000272	0.00236	CcSEcCtD
L-Arginine—Headache—Etoposide—urinary bladder cancer	0.000271	0.00234	CcSEcCtD
L-Arginine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000259	0.00224	CcSEcCtD
L-Arginine—Nausea—Etoposide—urinary bladder cancer	0.000257	0.00222	CcSEcCtD
L-Arginine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00025	0.00216	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—RHOA—urinary bladder cancer	0.000247	0.00249	CbGpPWpGaD
L-Arginine—Anorexia—Methotrexate—urinary bladder cancer	0.000247	0.00213	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000245	0.00247	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTT1—urinary bladder cancer	0.000244	0.00246	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000242	0.0021	CcSEcCtD
L-Arginine—NOS3—AGE/RAGE pathway—MMP9—urinary bladder cancer	0.000242	0.00244	CbGpPWpGaD
L-Arginine—Tachycardia—Epirubicin—urinary bladder cancer	0.000236	0.00205	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—urinary bladder cancer	0.000235	0.00237	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000234	0.00203	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—RHOA—urinary bladder cancer	0.000234	0.00236	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—urinary bladder cancer	0.000233	0.00235	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—FAS—urinary bladder cancer	0.000232	0.00234	CbGpPWpGaD
L-Arginine—Anorexia—Epirubicin—urinary bladder cancer	0.000231	0.002	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.00023	0.00232	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—RRM2—urinary bladder cancer	0.000225	0.00227	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000225	0.00227	CbGpPWpGaD
L-Arginine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000225	0.00195	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000224	0.00194	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—urinary bladder cancer	0.000223	0.00225	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—SRC—urinary bladder cancer	0.000223	0.00225	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—urinary bladder cancer	0.000223	0.00225	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NQO1—urinary bladder cancer	0.000222	0.00224	CbGpPWpGaD
L-Arginine—NOS2—Disease—GSTO2—urinary bladder cancer	0.000221	0.00223	CbGpPWpGaD
L-Arginine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000219	0.00189	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—SRC—urinary bladder cancer	0.000218	0.0022	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—urinary bladder cancer	0.000217	0.00219	CbGpPWpGaD
L-Arginine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000217	0.00187	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	0.000217	0.00218	CbGpPWpGaD
L-Arginine—Anorexia—Doxorubicin—urinary bladder cancer	0.000214	0.00185	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000211	0.00182	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—urinary bladder cancer	0.000209	0.00211	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ENO2—urinary bladder cancer	0.000209	0.00211	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—HPGDS—urinary bladder cancer	0.000209	0.00211	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—RHOA—urinary bladder cancer	0.000207	0.00209	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL2—urinary bladder cancer	0.000207	0.00209	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—CXCL8—urinary bladder cancer	0.000205	0.00207	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—urinary bladder cancer	0.000205	0.00207	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000204	0.00206	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NQO1—urinary bladder cancer	0.000203	0.00205	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000203	0.00205	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTT1—urinary bladder cancer	0.000202	0.00204	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—urinary bladder cancer	0.000202	0.00203	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—SRC—urinary bladder cancer	0.000202	0.00203	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TYMP—urinary bladder cancer	0.0002	0.00202	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—urinary bladder cancer	0.0002	0.00202	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.0002	0.00201	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—IL2—urinary bladder cancer	0.000196	0.00198	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MMP9—urinary bladder cancer	0.000196	0.00198	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—urinary bladder cancer	0.000196	0.00197	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—RHOA—urinary bladder cancer	0.000196	0.00197	CbGpPWpGaD
L-Arginine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000195	0.00169	CcSEcCtD
L-Arginine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000191	0.00165	CcSEcCtD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000187	0.00189	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000185	0.00187	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSTP1—urinary bladder cancer	0.000185	0.00187	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NAT2—urinary bladder cancer	0.000181	0.00183	CbGpPWpGaD
L-Arginine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000178	0.00154	CcSEcCtD
L-Arginine—NOS3—SHP2 signaling—HRAS—urinary bladder cancer	0.000174	0.00176	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—TYMS—urinary bladder cancer	0.000172	0.00174	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC19A1—urinary bladder cancer	0.000172	0.00173	CbGpPWpGaD
L-Arginine—NOS3—Disease—GSTO2—urinary bladder cancer	0.000172	0.00173	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSTM1—urinary bladder cancer	0.00017	0.00172	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NCOR1—urinary bladder cancer	0.00017	0.00172	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTP1—urinary bladder cancer	0.000169	0.00171	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NQO1—urinary bladder cancer	0.000168	0.0017	CbGpPWpGaD
L-Arginine—NOS2—Disease—PRSS3—urinary bladder cancer	0.000168	0.00169	CbGpPWpGaD
L-Arginine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000165	0.00143	CcSEcCtD
L-Arginine—Vomiting—Methotrexate—urinary bladder cancer	0.000165	0.00142	CcSEcCtD
L-Arginine—Rash—Methotrexate—urinary bladder cancer	0.000163	0.00141	CcSEcCtD
L-Arginine—Dermatitis—Methotrexate—urinary bladder cancer	0.000163	0.00141	CcSEcCtD
L-Arginine—AZIN2—Metabolism—GPX1—urinary bladder cancer	0.000163	0.00164	CbGpPWpGaD
L-Arginine—Headache—Methotrexate—urinary bladder cancer	0.000162	0.0014	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—MYC—urinary bladder cancer	0.000162	0.00163	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ERCC2—urinary bladder cancer	0.00016	0.00161	CbGpPWpGaD
L-Arginine—NOS2—Disease—HDAC4—urinary bladder cancer	0.00016	0.00161	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—urinary bladder cancer	0.000158	0.0016	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TYMS—urinary bladder cancer	0.000157	0.00159	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—RRM2—urinary bladder cancer	0.000156	0.00158	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NCOR1—urinary bladder cancer	0.000156	0.00157	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTM1—urinary bladder cancer	0.000156	0.00157	CbGpPWpGaD
L-Arginine—Vomiting—Epirubicin—urinary bladder cancer	0.000154	0.00133	CcSEcCtD
L-Arginine—Nausea—Methotrexate—urinary bladder cancer	0.000154	0.00133	CcSEcCtD
L-Arginine—Rash—Epirubicin—urinary bladder cancer	0.000153	0.00132	CcSEcCtD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000153	0.00154	CbGpPWpGaD
L-Arginine—Dermatitis—Epirubicin—urinary bladder cancer	0.000153	0.00132	CcSEcCtD
L-Arginine—Headache—Epirubicin—urinary bladder cancer	0.000152	0.00131	CcSEcCtD
L-Arginine—NOS3—Metabolism—GSTZ1—urinary bladder cancer	0.000152	0.00153	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—SRC—urinary bladder cancer	0.000152	0.00153	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TNF—urinary bladder cancer	0.000151	0.00152	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—MTHFR—urinary bladder cancer	0.00015	0.00152	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GPX1—urinary bladder cancer	0.000149	0.0015	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000147	0.00149	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ERCC2—urinary bladder cancer	0.000146	0.00148	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IFNA2—urinary bladder cancer	0.000145	0.00147	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ENO2—urinary bladder cancer	0.000145	0.00146	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—HPGDS—urinary bladder cancer	0.000145	0.00146	CbGpPWpGaD
L-Arginine—Nausea—Epirubicin—urinary bladder cancer	0.000144	0.00124	CcSEcCtD
L-Arginine—NOS3—Metabolism—GSTO2—urinary bladder cancer	0.000144	0.00145	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NAT1—urinary bladder cancer	0.000144	0.00145	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—SRC—urinary bladder cancer	0.000143	0.00144	CbGpPWpGaD
L-Arginine—Vomiting—Doxorubicin—urinary bladder cancer	0.000142	0.00123	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—urinary bladder cancer	0.000142	0.00143	CbGpPWpGaD
L-Arginine—Rash—Doxorubicin—urinary bladder cancer	0.000141	0.00122	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000141	0.00122	CcSEcCtD
L-Arginine—Headache—Doxorubicin—urinary bladder cancer	0.00014	0.00121	CcSEcCtD
L-Arginine—ARG2—Metabolism—GSTP1—urinary bladder cancer	0.00014	0.00142	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTT1—urinary bladder cancer	0.00014	0.00142	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—ERBB2—urinary bladder cancer	0.000138	0.00139	CbGpPWpGaD
L-Arginine—ASL—Metabolism—MTHFR—urinary bladder cancer	0.000138	0.00139	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000137	0.00138	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000137	0.00138	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000135	0.00136	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC19A1—urinary bladder cancer	0.000134	0.00135	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—urinary bladder cancer	0.000133	0.00115	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—TP53—urinary bladder cancer	0.000133	0.00134	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—UGT2B7—urinary bladder cancer	0.000132	0.00133	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TYMS—urinary bladder cancer	0.00013	0.00132	CbGpPWpGaD
L-Arginine—NOS3—Disease—PRSS3—urinary bladder cancer	0.00013	0.00131	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NCOR1—urinary bladder cancer	0.000129	0.0013	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTM1—urinary bladder cancer	0.000129	0.0013	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000127	0.00128	CbGpPWpGaD
L-Arginine—NOS2—Disease—LIG1—urinary bladder cancer	0.000127	0.00128	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—urinary bladder cancer	0.000126	0.00127	CbGpPWpGaD
L-Arginine—NOS3—Disease—HDAC4—urinary bladder cancer	0.000124	0.00125	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GPX1—urinary bladder cancer	0.000124	0.00125	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PPARG—urinary bladder cancer	0.000122	0.00123	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—EP300—urinary bladder cancer	0.000121	0.00122	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ERCC2—urinary bladder cancer	0.000121	0.00122	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—urinary bladder cancer	0.000119	0.0012	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP4B1—urinary bladder cancer	0.000118	0.00119	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTEN—urinary bladder cancer	0.000117	0.00118	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CREBBP—urinary bladder cancer	0.000117	0.00118	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NQO1—urinary bladder cancer	0.000117	0.00118	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—MTHFR—urinary bladder cancer	0.000114	0.00115	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNA2—urinary bladder cancer	0.000113	0.00114	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC19A1—urinary bladder cancer	0.000112	0.00113	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PPARG—urinary bladder cancer	0.000112	0.00112	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PRSS3—urinary bladder cancer	0.000109	0.0011	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—SRC—urinary bladder cancer	0.000109	0.0011	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CREBBP—urinary bladder cancer	0.000107	0.00108	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—urinary bladder cancer	0.000107	0.00108	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PLAU—urinary bladder cancer	0.000103	0.00104	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000103	0.00104	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—urinary bladder cancer	0.000101	0.00102	CbGpPWpGaD
L-Arginine—NOS3—Disease—LIG1—urinary bladder cancer	9.86e-05	0.000995	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTP1—urinary bladder cancer	9.73e-05	0.000981	CbGpPWpGaD
L-Arginine—NOS2—Disease—ENO2—urinary bladder cancer	9.69e-05	0.000977	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—urinary bladder cancer	9.59e-05	0.000968	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—urinary bladder cancer	9.54e-05	0.000962	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PPARG—urinary bladder cancer	9.24e-05	0.000932	CbGpPWpGaD
L-Arginine—NOS2—Disease—RBX1—urinary bladder cancer	9.18e-05	0.000926	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TYMS—urinary bladder cancer	9.04e-05	0.000912	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—urinary bladder cancer	9.01e-05	0.000909	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NCOR1—urinary bladder cancer	8.94e-05	0.000902	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTM1—urinary bladder cancer	8.94e-05	0.000902	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CREBBP—urinary bladder cancer	8.88e-05	0.000895	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—urinary bladder cancer	8.77e-05	0.000885	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMP—urinary bladder cancer	8.71e-05	0.000879	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HDAC4—urinary bladder cancer	8.69e-05	0.000877	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—urinary bladder cancer	8.68e-05	0.000875	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GPX1—urinary bladder cancer	8.56e-05	0.000863	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—CREBBP—urinary bladder cancer	8.51e-05	0.000858	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ERCC2—urinary bladder cancer	8.4e-05	0.000848	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IGF1—urinary bladder cancer	8.4e-05	0.000847	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTEN—urinary bladder cancer	8.37e-05	0.000844	CbGpPWpGaD
L-Arginine—NOS2—Disease—JAG1—urinary bladder cancer	8.22e-05	0.000829	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLAU—urinary bladder cancer	8.01e-05	0.000808	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—EP300—urinary bladder cancer	7.98e-05	0.000805	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—MTHFR—urinary bladder cancer	7.9e-05	0.000797	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NAT2—urinary bladder cancer	7.88e-05	0.000795	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—RHOA—urinary bladder cancer	7.7e-05	0.000776	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—urinary bladder cancer	7.66e-05	0.000772	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—urinary bladder cancer	7.65e-05	0.000772	CbGpPWpGaD
L-Arginine—NOS3—Disease—ENO2—urinary bladder cancer	7.52e-05	0.000758	CbGpPWpGaD
L-Arginine—ASL—Metabolism—EP300—urinary bladder cancer	7.3e-05	0.000736	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLI1—urinary bladder cancer	7.28e-05	0.000735	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—urinary bladder cancer	7.27e-05	0.000733	CbGpPWpGaD
L-Arginine—NOS3—Disease—RBX1—urinary bladder cancer	7.13e-05	0.000719	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—RRM2—urinary bladder cancer	6.8e-05	0.000686	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CREBBP—urinary bladder cancer	6.61e-05	0.000666	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IGF1—urinary bladder cancer	6.52e-05	0.000658	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—urinary bladder cancer	6.46e-05	0.000651	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.42e-05	0.000647	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARG—urinary bladder cancer	6.41e-05	0.000646	CbGpPWpGaD
L-Arginine—NOS3—Disease—JAG1—urinary bladder cancer	6.38e-05	0.000644	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—urinary bladder cancer	6.34e-05	0.000639	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.31e-05	0.000637	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HPGDS—urinary bladder cancer	6.3e-05	0.000635	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ENO2—urinary bladder cancer	6.3e-05	0.000635	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CREBBP—urinary bladder cancer	6.15e-05	0.000621	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTT1—urinary bladder cancer	6.11e-05	0.000616	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—EP300—urinary bladder cancer	6.05e-05	0.00061	CbGpPWpGaD
L-Arginine—NOS2—Disease—NCOR1—urinary bladder cancer	5.98e-05	0.000603	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—RHOA—urinary bladder cancer	5.98e-05	0.000603	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EP300—urinary bladder cancer	5.8e-05	0.000584	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—urinary bladder cancer	5.64e-05	0.000568	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERCC2—urinary bladder cancer	5.63e-05	0.000567	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTHFR—urinary bladder cancer	5.29e-05	0.000533	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—urinary bladder cancer	5.27e-05	0.000532	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NQO1—urinary bladder cancer	5.08e-05	0.000512	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—urinary bladder cancer	5.04e-05	0.000508	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—urinary bladder cancer	5.01e-05	0.000506	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RBX1—urinary bladder cancer	4.99e-05	0.000504	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGFR3—urinary bladder cancer	4.84e-05	0.000488	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.82e-05	0.000486	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TSC1—urinary bladder cancer	4.69e-05	0.000473	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—urinary bladder cancer	4.67e-05	0.000471	CbGpPWpGaD
L-Arginine—NOS3—Disease—NCOR1—urinary bladder cancer	4.65e-05	0.000469	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EP300—urinary bladder cancer	4.5e-05	0.000454	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAG1—urinary bladder cancer	4.47e-05	0.000451	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—urinary bladder cancer	4.39e-05	0.000443	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—urinary bladder cancer	4.38e-05	0.000441	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERCC2—urinary bladder cancer	4.37e-05	0.000441	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTP1—urinary bladder cancer	4.23e-05	0.000427	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—EP300—urinary bladder cancer	4.19e-05	0.000423	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—urinary bladder cancer	4.15e-05	0.000418	CbGpPWpGaD
L-Arginine—NOS2—Disease—CREBBP—urinary bladder cancer	4.12e-05	0.000415	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTHFR—urinary bladder cancer	4.11e-05	0.000414	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—urinary bladder cancer	4.09e-05	0.000413	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—urinary bladder cancer	3.97e-05	0.0004	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—urinary bladder cancer	3.94e-05	0.000397	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—urinary bladder cancer	3.89e-05	0.000392	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NCOR1—urinary bladder cancer	3.89e-05	0.000392	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGFR3—urinary bladder cancer	3.76e-05	0.000379	CbGpPWpGaD
L-Arginine—NOS2—Disease—RHOA—urinary bladder cancer	3.73e-05	0.000376	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GPX1—urinary bladder cancer	3.73e-05	0.000376	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ERCC2—urinary bladder cancer	3.66e-05	0.000369	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—urinary bladder cancer	3.62e-05	0.000365	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—S100B—urinary bladder cancer	3.62e-05	0.000365	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERBB2—urinary bladder cancer	3.45e-05	0.000348	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MTHFR—urinary bladder cancer	3.44e-05	0.000347	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—urinary bladder cancer	3.37e-05	0.00034	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NCOR1—urinary bladder cancer	3.25e-05	0.000328	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—urinary bladder cancer	3.22e-05	0.000325	CbGpPWpGaD
L-Arginine—NOS3—Disease—CREBBP—urinary bladder cancer	3.2e-05	0.000323	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—urinary bladder cancer	3.08e-05	0.000311	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDKN1A—urinary bladder cancer	2.95e-05	0.000297	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—urinary bladder cancer	2.94e-05	0.000297	CbGpPWpGaD
L-Arginine—NOS3—Disease—RHOA—urinary bladder cancer	2.89e-05	0.000292	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—urinary bladder cancer	2.87e-05	0.000289	CbGpPWpGaD
L-Arginine—NOS2—Disease—EP300—urinary bladder cancer	2.81e-05	0.000283	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARG—urinary bladder cancer	2.79e-05	0.000281	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—urinary bladder cancer	2.73e-05	0.000275	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CREBBP—urinary bladder cancer	2.68e-05	0.00027	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERBB2—urinary bladder cancer	2.68e-05	0.00027	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGFR3—urinary bladder cancer	2.63e-05	0.000265	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—urinary bladder cancer	2.62e-05	0.000264	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ESR1—urinary bladder cancer	2.56e-05	0.000258	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—urinary bladder cancer	2.44e-05	0.000247	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—urinary bladder cancer	2.39e-05	0.000241	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDKN1A—urinary bladder cancer	2.29e-05	0.000231	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—urinary bladder cancer	2.28e-05	0.00023	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—urinary bladder cancer	2.26e-05	0.000228	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CREBBP—urinary bladder cancer	2.24e-05	0.000226	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IGF1—urinary bladder cancer	2.21e-05	0.000223	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—urinary bladder cancer	2.19e-05	0.000221	CbGpPWpGaD
L-Arginine—NOS3—Disease—EP300—urinary bladder cancer	2.18e-05	0.00022	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—urinary bladder cancer	2.12e-05	0.000214	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RHOA—urinary bladder cancer	2.03e-05	0.000204	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—urinary bladder cancer	1.92e-05	0.000194	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—urinary bladder cancer	1.91e-05	0.000193	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—urinary bladder cancer	1.9e-05	0.000191	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ERBB2—urinary bladder cancer	1.88e-05	0.000189	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—urinary bladder cancer	1.86e-05	0.000187	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—EP300—urinary bladder cancer	1.82e-05	0.000184	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—urinary bladder cancer	1.78e-05	0.000179	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—urinary bladder cancer	1.75e-05	0.000177	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—urinary bladder cancer	1.7e-05	0.000171	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—urinary bladder cancer	1.66e-05	0.000167	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—urinary bladder cancer	1.61e-05	0.000162	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.6e-05	0.000162	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—urinary bladder cancer	1.6e-05	0.000161	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EP300—urinary bladder cancer	1.53e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—urinary bladder cancer	1.49e-05	0.00015	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—urinary bladder cancer	1.48e-05	0.00015	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—urinary bladder cancer	1.33e-05	0.000134	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—urinary bladder cancer	1.3e-05	0.000131	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—urinary bladder cancer	1.23e-05	0.000124	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—urinary bladder cancer	1.09e-05	0.00011	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—urinary bladder cancer	1.04e-05	0.000105	CbGpPWpGaD
